AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
TIA-1 EXPRESSION IN CD30-LYMPHOCYTE DIFFERENTIATION( LYMPHOMATOID PAPULOSIS SUPPORTS CYTOTOXIC T)
Authors: HUHN KM VONDERHEID EC SALHANY KE
Citation: Km. Huhn et al., TIA-1 EXPRESSION IN CD30-LYMPHOCYTE DIFFERENTIATION( LYMPHOMATOID PAPULOSIS SUPPORTS CYTOTOXIC T), Modern pathology, 11(1), 1998, pp. 131-131
RADIOTHERAPY FOR UNILESIONAL MYCOSIS-FUNGOIDES
Authors: MICAILY B MIYAMOTO C KANTOR G LESSIN S ROOK A BRADY L GOODMAN R VONDERHEID EC
Citation: B. Micaily et al., RADIOTHERAPY FOR UNILESIONAL MYCOSIS-FUNGOIDES, International journal of radiation oncology, biology, physics, 42(2), 1998, pp. 361-364
USE OF SERUM-SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS TO MONITOR THE PROGRESSION OF CUTANEOUS T-CELL LYMPHOMA
Authors: VONDERHEID EC ZHANG Q LESSIN SR POLANSKY M ABRAMS JT BIGLER RD WASIK MA
Citation: Ec. Vonderheid et al., USE OF SERUM-SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS TO MONITOR THE PROGRESSION OF CUTANEOUS T-CELL LYMPHOMA, Journal of the American Academy of Dermatology, 38(2), 1998, pp. 207-220
THE PROGNOSTIC-SIGNIFICANCE OF DELAYED-HYPERSENSITIVITY TO DINITROCHLOROBENZENE AND MECHLORETHAMINE HYDROCHLORIDE IN CUTANEOUS T-CELL LYMPHOMA
Authors: VONDERHEID EC EKBOTE SK KERRIGAN K KALMANSON JD VANSCOTT EJ ROOK AH ABRAMS JT
Citation: Ec. Vonderheid et al., THE PROGNOSTIC-SIGNIFICANCE OF DELAYED-HYPERSENSITIVITY TO DINITROCHLOROBENZENE AND MECHLORETHAMINE HYDROCHLORIDE IN CUTANEOUS T-CELL LYMPHOMA, Journal of investigative dermatology, 110(6), 1998, pp. 946-950
CD30-NOVO AND IN PATIENTS WITH MYCOSIS-FUNGOIDES EXPRESSES A CYTOTOXIC T-CELL PHENOTYPE( LYMPHOMATOID PAPULOSIS PRESENTING DE)
Authors: HUHN KM VONDERHEID EC SALHANY KE
Citation: Km. Huhn et al., CD30-NOVO AND IN PATIENTS WITH MYCOSIS-FUNGOIDES EXPRESSES A CYTOTOXIC T-CELL PHENOTYPE( LYMPHOMATOID PAPULOSIS PRESENTING DE), Journal of investigative dermatology, 110(4), 1998, pp. 566-566
INTERLEUKIN-12 IS SAFE AND EFFECTIVE THERAPY FOR CUTANEOUS T-CELL LYMPHOMA
Authors: ROOK AH YOO EK WOOD GS ELENITSAS R FOX FE NIU Z SHERMAN ML KAO D LESSIN SR VONDERHEID EC
Citation: Ah. Rook et al., INTERLEUKIN-12 IS SAFE AND EFFECTIVE THERAPY FOR CUTANEOUS T-CELL LYMPHOMA, Journal of investigative dermatology, 110(4), 1998, pp. 679-679
LOCALIZED CUTANEOUS AMYLOIDOSIS ASSOCIATED WITH MYCOSIS-FUNGOIDES
Authors: ROMERO LS KANTOR GR LEVIN MW VONDERHEID EC
Citation: Ls. Romero et al., LOCALIZED CUTANEOUS AMYLOIDOSIS ASSOCIATED WITH MYCOSIS-FUNGOIDES, Journal of the American Academy of Dermatology, 37(1), 1997, pp. 124-127
T-CELL RECEPTOR (TCR) DNA VACCINATION IN CUTANEOUS T-CELL LYMPHOMA (CTCL)
Authors: LESSIN SR FOX FF LI G BENOIT BM FANG O VONDERHEID EC OLSEN E HIGGINS T GINSBERG RS ROOK AH WEINER DB WILLIAMS WV
Citation: Sr. Lessin et al., T-CELL RECEPTOR (TCR) DNA VACCINATION IN CUTANEOUS T-CELL LYMPHOMA (CTCL), Journal of investigative dermatology, 108(4), 1997, pp. 199-199
METHOTREXATE IS EFFECTIVE THERAPY FOR LYMPHOMATOID PAPULOSIS AND OTHER PRIMARY CUTANEOUS CD30-POSITIVE LYMPHOPROLIFERATIVE DISORDERS
Authors: VONDERHEID EC SAJJADIAN A KADIN ME
Citation: Ec. Vonderheid et al., METHOTREXATE IS EFFECTIVE THERAPY FOR LYMPHOMATOID PAPULOSIS AND OTHER PRIMARY CUTANEOUS CD30-POSITIVE LYMPHOPROLIFERATIVE DISORDERS, Journal of the American Academy of Dermatology, 34(3), 1996, pp. 470-481
CUTANEOUS CD56-CELL LYMPHOMA ASSOCIATED WITH HIGH SERUM CONCENTRATIONOF IL-2( LARGE T)
Authors: WASIK MA SACKSTEIN R NOVICK D BUTMARC JR ZHANG QA VONDERHEID EC KADIN ME
Citation: Ma. Wasik et al., CUTANEOUS CD56-CELL LYMPHOMA ASSOCIATED WITH HIGH SERUM CONCENTRATIONOF IL-2( LARGE T), Human pathology, 27(7), 1996, pp. 738-744
ACTIVATION OF JAK STAT PROTEINS INVOLVED IN SIGNAL-TRANSDUCTION PATHWAY MEDIATED BY RECEPTOR FOR INTERLEUKIN-2 IN MALIGNANT T-LYMPHOCYTES DERIVED FROM CUTANEOUS ANAPLASTIC LARGE T-CELL LYMPHOMA AND SEZARY-SYNDROME/
Authors: ZHANG Q NOWAK I VONDERHEID EC ROOK AH KADIN ME NOWELL PC SHAW LM WASIK MA
Citation: Q. Zhang et al., ACTIVATION OF JAK STAT PROTEINS INVOLVED IN SIGNAL-TRANSDUCTION PATHWAY MEDIATED BY RECEPTOR FOR INTERLEUKIN-2 IN MALIGNANT T-LYMPHOCYTES DERIVED FROM CUTANEOUS ANAPLASTIC LARGE T-CELL LYMPHOMA AND SEZARY-SYNDROME/, Proceedings of the National Academy of Sciences of the United Statesof America, 93(17), 1996, pp. 9148-9153
DETECTION OF THE SAME DOMINANT T-CELL CLONE IN MULTIPLE LYMPHOMATOID PAPULOSIS (LYP) LESIONS AND ASSOCIATED LYMPHOMAS
Authors: CHOTT A VONDERHEID EC MIAO NN BALK SP KADIN ME
Citation: A. Chott et al., DETECTION OF THE SAME DOMINANT T-CELL CLONE IN MULTIPLE LYMPHOMATOID PAPULOSIS (LYP) LESIONS AND ASSOCIATED LYMPHOMAS, Laboratory investigation, 74(1), 1996, pp. 633-633
THE SAME DOMINANT T-CELL CLONE IS PRESENT IN MULTIPLE REGRESSING SKIN-LESIONS AND ASSOCIATED T-CELL LYMPHOMAS OF PATIENTS WITH LYMPHOMATOIDPAPULOSIS
Authors: CHOTT A VONDERHEID EC OLBRICHT S MIAO NN BALK SP KADIN ME
Citation: A. Chott et al., THE SAME DOMINANT T-CELL CLONE IS PRESENT IN MULTIPLE REGRESSING SKIN-LESIONS AND ASSOCIATED T-CELL LYMPHOMAS OF PATIENTS WITH LYMPHOMATOIDPAPULOSIS, Journal of investigative dermatology, 106(4), 1996, pp. 696-700
ANALYSIS OF P53 AND MDM-2 EXPRESSION IN 18 PATIENTS WITH SEZARY-SYNDROME
Authors: MARKS DI VONDERHEID EC KURZ BW BIGLER RD SINHA K MORGAN DA SUKMAN A NOWELL PC HAINES DS
Citation: Di. Marks et al., ANALYSIS OF P53 AND MDM-2 EXPRESSION IN 18 PATIENTS WITH SEZARY-SYNDROME, British Journal of Haematology, 92(4), 1996, pp. 890-899
DETECTION OF CIRCULATING NEOPLASTIC T-CELLS IN PATIENTS WITH SEZARY-SYNDROME AND ERYTHRODERMIC MYCOSIS-FUNGOIDES BY 3-COLOR IMMUNOFLUORESCENCE FLOW-CYTOMETRY
Authors: REUBEN JM VONDERHEID EC LEE BN BIGLER RD LESSIN SR PARKER K
Citation: Jm. Reuben et al., DETECTION OF CIRCULATING NEOPLASTIC T-CELLS IN PATIENTS WITH SEZARY-SYNDROME AND ERYTHRODERMIC MYCOSIS-FUNGOIDES BY 3-COLOR IMMUNOFLUORESCENCE FLOW-CYTOMETRY, Blood, 88(10), 1996, pp. 3478-3478
INCREASED SERUM CONCENTRATION OF THE SOLUBLE INTERLEUKIN-2 RECEPTOR IN CUTANEOUS T-CELL LYMPHOMA - CLINICAL AND PROGNOSTIC IMPLICATIONS
Authors: WASIK MA VONDERHEID EC BIGLER RD MARTI R LESSIN SR POLANSKY M KADIN ME
Citation: Ma. Wasik et al., INCREASED SERUM CONCENTRATION OF THE SOLUBLE INTERLEUKIN-2 RECEPTOR IN CUTANEOUS T-CELL LYMPHOMA - CLINICAL AND PROGNOSTIC IMPLICATIONS, Archives of dermatology, 132(1), 1996, pp. 42-47
CUTANEOUS T-CELL LYMPHOMA IN ASSOCIATION WITH SILICONE BREAST IMPLANTS
Authors: DUVIC M MOORE D MENTER A VONDERHEID EC
Citation: M. Duvic et al., CUTANEOUS T-CELL LYMPHOMA IN ASSOCIATION WITH SILICONE BREAST IMPLANTS, Journal of the American Academy of Dermatology, 32(6), 1995, pp. 939-942
REDUCED SURFACE EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA RECEPTOR-TYPE-II IN MITOGEN-ACTIVATED T-CELLS FROM SEZARY PATIENTS
Authors: CAPOCASALE RJ LAMB RJ VONDERHEID EC FOX FE ROOK AH NOWELL PC MOOREN JS
Citation: Rj. Capocasale et al., REDUCED SURFACE EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA RECEPTOR-TYPE-II IN MITOGEN-ACTIVATED T-CELLS FROM SEZARY PATIENTS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(12), 1995, pp. 5501-5505
INCREASED SERUM CONCENTRATION OF THE SOLUBLE INTERLEUKIN-2 RECEPTOR IN CUTANEOUS T-CELL LYMPHOMA - CLINICAL AND PROGNOSTIC IMPLICATIONS
Authors: WASIK MA VONDERHEID EC BIGLER RD MARTL R LESSIN S POLANSKY M
Citation: Ma. Wasik et al., INCREASED SERUM CONCENTRATION OF THE SOLUBLE INTERLEUKIN-2 RECEPTOR IN CUTANEOUS T-CELL LYMPHOMA - CLINICAL AND PROGNOSTIC IMPLICATIONS, Laboratory investigation, 72(1), 1995, pp. 122-122
IL-12 REVERSES CYTOKINE AND IMMUNE ABNORMALITIES IN SEZARY-SYNDROME
Authors: ROOK AH KUBIN M CASSIN M VONDERHEID EC VOWELS BR WOLFE JT WOLF SF SINGH A TRINCHIERI G LESSIN SR
Citation: Ah. Rook et al., IL-12 REVERSES CYTOKINE AND IMMUNE ABNORMALITIES IN SEZARY-SYNDROME, The Journal of immunology, 154(3), 1995, pp. 1491-1498
MYCOSIS-FUNGOIDES PALMARIS ET PLANTARIS
Authors: RESNIK KS KANTOR GR LESSIN SR KADIN ME CHOOBACK L COOPER HS VONDERHEID EC
Citation: Ks. Resnik et al., MYCOSIS-FUNGOIDES PALMARIS ET PLANTARIS, Archives of dermatology, 131(9), 1995, pp. 1052-1056
CD40L IS EXPRESSED ON ACTIVATED CELLS OF SEZARY PATIENTS WITH ELEVATED IGE
Authors: BIGLER RD BOSELLI C SPRIGGS MK ARMITAGE RJ VONDERHEID EC
Citation: Rd. Bigler et al., CD40L IS EXPRESSED ON ACTIVATED CELLS OF SEZARY PATIENTS WITH ELEVATED IGE, The FASEB journal, 8(5), 1994, pp. 10001006-10001006
DETECTION AND EXPRESSION OF HTLV-I TAX REX GENE IN T-CELLS FROM PATIENTS WITH CTCL/
Authors: GHOSH SK ABRAMS JT TERUNUMA H VONDERHEID EC DEFREITAS E
Citation: Sk. Ghosh et al., DETECTION AND EXPRESSION OF HTLV-I TAX REX GENE IN T-CELLS FROM PATIENTS WITH CTCL/, AIDS research and human retroviruses, 10(4), 1994, pp. 468-468
EXTRACORPOREAL PHOTOPHERESIS AND RECOMBINANT INTERFERON ALFA-2B IN SEZARY-SYNDROME - USE OF DUAL MARKER LABELING TO MONITOR THERAPEUTIC RESPONSE
Authors: VONDERHEID EC BIGLER RD GREENBERG AS NEUKUM SJ MICAILY B
Citation: Ec. Vonderheid et al., EXTRACORPOREAL PHOTOPHERESIS AND RECOMBINANT INTERFERON ALFA-2B IN SEZARY-SYNDROME - USE OF DUAL MARKER LABELING TO MONITOR THERAPEUTIC RESPONSE, American journal of clinical oncology, 17(3), 1994, pp. 255-263
INTERLEUKIN-12 (IL-12) REVERSES CYTOKINE AND IMMUNE ABNORMALITIES OF SEZARY-SYNDROME
Authors: ROOK AH KUBIN M VONDERHEID EC CASSIN M VOWELS BR WOLFE JT WOLF S TRINCHIERI G LESSIN SR
Citation: Ah. Rook et al., INTERLEUKIN-12 (IL-12) REVERSES CYTOKINE AND IMMUNE ABNORMALITIES OF SEZARY-SYNDROME, Journal of investigative dermatology, 102(4), 1994, pp. 557-557
Risultati: 1-25 | 26-30